Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice-Reference-Cited by-同舟云学术

Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice

Published:2009-02 Issue:2 Volume:53 Page:791-793
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Baz Mariana¹,Abed Yacine¹,Nehmé Benjamin¹,Boivin Guy¹

Affiliation:

1. Research Center in Infectious Diseases, CHUQ-CHUL, and Laval University, Québec City, Québec, Canada

Abstract

ABSTRACT The new oral neuraminidase (NA) inhibitor A-322278 was evaluated in mice infected with influenza A/H1N1 wild-type virus or the oseltamivir-resistant (H274Y mutant) virus. A-322278 decreased mortality rates and lung virus titers significantly more than oseltamivir in mice infected with the NA H274Y mutant when therapy was started 4 h before or even 48 h after infection.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01276-08

Reference13 articles.

1. Abed, Y., and G. Boivin. 2006. Treatment of respiratory virus infections. Antivir. Res.70:1-16.

2. Abed, Y., N. Goyette, and G. Boivin. 2004. A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus. Antivir. Ther.9:577-581.

3. Abed, Y., B. Nehme, M. Baz, and G. Boivin. 2008. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes. Antivir. Res.77:163-166.

4. Baz, M., Y. Abed, J. McDonald, and G. Boivin. 2006. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin. Infect. Dis.43:1555-1561.

5. DeGoey, D. A., H. J. Chen, W. J. Flosi, D. J. Grampovnik, C. M. Yeung, L. L. Klein, and D. J. Kempf. 2002. Enantioselective synthesis of antiinfluenza compound A-315675. J. Org. Chem.67:5445-5453.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations in influenza A virus during amantadine-oseltamivir combination therapy;Journal of Pediatric Infectious Diseases;2015-07-28

2. Fatores relacionados ao óbito pela Influenza Pandêmica A (H1N1) 2009 em pacientes tratados com Oseltamivir;Revista Brasileira de Enfermagem;2013-10

3. Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents;Antiviral Research;2012-10

4. [C+NC+CC] Coupling-Enabled Synthesis of Influenza Neuramidase Inhibitor A-315675;Organic Letters;2012-02-17

5. Influenza Drug Resistance;Seminars in Respiratory and Critical Care Medicine;2011-08